Discovering Solutions through Clinical Trials

Intrepid Research in Cincinnati, Ohio, conducts clinical research in a variety fields such as internal medicine, sleep medicine, neuroscience, diabetes, pulmonary diseases, and many more. We take pride in our contributions to your health through the advancements gained from our clinical research. Let us know which clinical trial is right for you.

Current Trials

If you have Narcolepsy, you may be able to help with research to develop new treatment options.

Takeda Pharmaceuticals is evaluating a novel investigational drug that may address the root cause of Narcolepsy. Currently, all therapies and treatment options are directed to treat only the symptoms of Narcolepsy. This clinical research may lead to a life changing treatment.

We are looking for participants that:

  • Are between the ages of 18 and 65
  • Have been diagnosed with Narcolepsy with or without cataplexy
  • Experience excessive daytime sleepiness
  • Are willing and able to comply with the study procedures
  • Meet additional requirements as determined by a screening process

A study doctor or staff can explain to you in greater detail other requirements and eligibility criteria you would have to meet in order to participate in the study.

If you are interested or want to learn more about this study call 513-977-8898 or go to https://intrepidresearchoh.com/ and submit your information.

Intrepid Research is now enrolling people suffering from Narcolepsy to participate in a clinical study to help develop better treatment options.

Suven Life Sciences is evaluating an investigational drug to improve the wakefulness of patients with Narcolepsy with or without cataplexy. Your participation could help others by contributing to medical research.

We are looking for participants that:

  • Are between the ages of 18 – 50
  • Have been diagnosed with Narcolepsy with or without cataplexy
  • Struggle with excessive daytime sleepiness and poor nighttime sleep habits
  • Are willing to comply with the study procedures
  • Meet additional requirements as determined by a screening process

A study doctor or staff can explain to you in greater detail other requirements and eligibility criteria you would have to meet in order to participate in the study.

If you are interested or want to learn more about this study call 513-977-8898 or go to https://intrepidresearchoh.com/ and submit your information.

Study Seeking Patients with Narcolepsy with or without Cataplexy

The Suven clinical research study’s objective is to evaluate the effectiveness of a test drug improving wakefulness patients with Narcolepsy with and without Cataplexy.

*Participants must meet these criteria:
• Between the ages of 18 and 75
• Have been diagnosed with Narcolepsy with or without Cataplexy (Na-1 or Na-2)
• Must not have habitual wake-up time after 8 AM as assessed by sleep diary, habitual sleep time of less than 6 hours, and habitual bedtime past 1 am as determined by sleep diary entries
• Must not have excessive caffeine (defined as greater than 600 mg/per day) use prior to baseline assessments or during the course of the trial
• Must not have nicotine dependence that influences sleep (eg, a patient who routinely awakens at night to smoke)
• Must not have an occupation requiring variable shift work, night shifts, or frequent overnight travel which disrupts sleep patterns

*Other criteria will apply
To see if you qualify contact us with the form below or call us at 513-977-8888.
Visit www.SuddenSleepStudy.com for additional information.

Tell us what trial you are interested in and someone will contact you back shortly.